Power supply monitoring for an implantable device
View Patent ↗A method and an apparatus for projecting an end of service (EOS) and/or an elective replacement indication (ERI) of a component in an implantable device and for determining an impedance experienced by a lead associated with the implantable device. An active charge depletion of an implantable device is determined. An inactive charge depletion of the implantable device is determined. A time period until an end of service (EOS) and/or elective replacement indication (ERI) of a power supply associated with the IMD based upon the active charge depletion, the inactive charge depletion, and the initial and final (EOS) battery charges, is determined. Furthermore, to determine the impedance described above, a substantially constant current signal is provided through a first terminal and a second terminal of the lead. A voltage across the first and second terminals is measured. An impedance across the first and second terminals is determined based upon the constant current signal and the measured voltage.
1. An implantable medical device, comprising:
an energy storage device to provide power for an operation performed by said implantable medical device, characterized by a total available electrical charge defined by the difference between an initial electrical charge and a final electrical charge;
a stimulation unit, operatively coupled to said energy storage device for providing a stimulation signal;
a memory adapted to store an active charge depletion rate determined during a calibration process and an inactive charge depletion rate determined during the calibration process; and
a controller operatively coupled to said stimulation unit and said energy storage device, said controller comprising:
an active charge depletion determination unit adapted to determine an electrical charge depleted from said energy storage device during stimulation operations of the implantable medical device based upon said active charge depletion rate and a predetermined current associated with said stimulation signal;
an inactive charge depletion determination unit adapted to determine an electrical charge depleted from said energy storage device during inactive periods based upon said inactive charge depletion rate and inactive periods of the implantable medical device; and
an end of service determination unit adapted to determine a time period until an end of service of said energy storage device based upon said total available electrical charge, said active charge depletion, and said inactive charge depletion.
2. The implantable device of claim 1 , wherein said implantable device is a vagus nerve stimulator device.
3. The implantable device of claim 1 , wherein said active charge depletion determination unit is adapted to determine an active charge depletion relating to at least one previous stimulation period performed by said implantable device.
4. The implantable device of claim 1 , wherein said active charge depletion determination unit is adapted to determine an active current usage rate for a future stimulation period to be performed by said implantable medical device.
5. The implantable medical device of claim 1 , wherein said inactive charge depletion determination unit is adapted to determine an idle charge depletion relating to at least one previous idle period of said implantable medical device.
6. The implantable medical device of claim 1 , wherein said inactive charge depletion determination unit is adapted to determine an idle current usage rate for a future idle period of said implantable medical device.
7. The implantable medical device of claim 1 , wherein said controller is adapted to generate an end of service signal based upon a determination that said time period until said end of service equals zero.
8. The implantable medical device of claim 1 , wherein said controller is adapted to generate an elective replacement indicator signal based upon a determination that said time period until said end of service is less than or equal to a predetermined period.
9. The implantable medical device of claim 8 , wherein said predetermined period is six months.